Two hormonal treatments now covered by the RAMQ

The provincial government announced that Prometrium et Estrogel will now be reimbursed unconditionally by the Régie de l’assurance maladie du Québec (RAMQ).

Organon Canada, which produces these two treatments, welcomes this news as this decision offers more choices for women suffering from menopausal symptoms.

“We are proud to have collaborated with the Ministry of Health and Social Services so that women in Quebec have access to more hormone therapy options that meet their needs,” said Michael Casia, President and CEO of Organon. Canada.

From its launch on June 3, 2021, the pharmaceutical company is committed to listening to women to hear and understand their health needs, including menopause.

The latter therefore wishes to find solutions to unresolved problems, and this collaboration with Quebec goes in this direction.

“Organon Canada intends to build on this momentum by focusing on women’s reproductive health, health issues specific to them, and diseases that particularly affect them,” said Amy Cairns, Executive Director for Women’s Health and established brands.

She adds that the company wants to help make a difference in women’s health.

(J.B.)

Share:

Facebook
Twitter
LinkedIn

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

On Key

Related Posts